Plunkett Research Online: Adamis Pharmaceuticals Corporation

ADAMIS PHARMACEUTICALS CORPORATION (ADMP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adamis Pharmaceuticals Corporation is an emerging pharmaceutical company focused on combining specialty pharmaceuticals and biotechnology to provide innovative medicines for patients and physicians. The company is currently primarily focused on its specialty pharmaceutical products, and is currentl.....



Adamis Pharmaceuticals Corporation
Ticker: ADMP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858-997-2400
Fax:
Address: 11682 El Camino Real
Suite 300
San Diego, CA 92130 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs
Allergy Medications
Respiratory Diseases
Oncology Products
Contraceptives
ContactsDescription
Eddie GloverCEO, Subsidiary
Dennis CarloCEO/Director/President
See More
Adamis Pharmaceuticals Corporation is an emerging pharmaceutical company focused on combining specialty pharmaceuticals and biotechnology to provide innovative medicines for patients and physicians. The company is currently primarily focused on its specialty pharmaceutical products, and is currentl.....See More See More

Auditor: Mayer Hoffman McCann P.C.
Legal Advisor: Weintraub Genshlea Chediak
$USD, In whole numbers,
except marked * or %
201620152014201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
US Compounding Inc
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: